Lingohr & Partner Asset Management Gmb H Bio N Tech Se Transaction History
Lingohr & Partner Asset Management Gmb H
- $55.2 Million
- Q2 2025
A detailed history of Lingohr & Partner Asset Management Gmb H transactions in Bio N Tech Se stock. As of the latest transaction made, Lingohr & Partner Asset Management Gmb H holds 6,822 shares of BNTX stock, worth $759,629. This represents 1.32% of its overall portfolio holdings.
Number of Shares
6,822
Previous 43,031
84.15%
Holding current value
$759,629
Previous $3.92 Million
81.47%
% of portfolio
1.32%
Previous 0.98%
Shares
3 transactions
Others Institutions Holding BNTX
# of Institutions
342Shares Held
40.2MCall Options Held
1.55MPut Options Held
1.46M-
Baillie Gifford & CO8.04MShares$895 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.23MShares$471 Million1.88% of portfolio
-
Primecap Management CO Pasadena, CA4.05MShares$451 Million0.31% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$211 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$201 Million0.84% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $27B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...